RAC1 and cardiac hypertrophy: Cardiomyocyte-specific deletion of Rac1 protected mice from AngII-induced cardiac hypertrophy, which was associated with reduced NOX2 activity and superoxide production as well as reduced ASK1/NFκB activation [41].